{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:54:26Z","timestamp":1778709266677,"version":"3.51.4"},"reference-count":27,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,8,29]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of the present study was to retrospectively analyse the data reported on antimicrobial resistance (AMR) in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>in six South-East Asia Region countries from 2009 to 2012 following the revitalisation of the WHO global Gonococcal Antimicrobial Surveillance Program (GASP).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>AMR data were generated for 7 antibiotics of 4675 isolates in 18 focal point laboratories using the calibrated dichotomous sensitivity (CDS) or Clinical and Laboratory Standards Institute (CLSI) methods and minimal inhibitory concentration testing by Etest in some of the centres. The results were interpreted using the breakpoints recommended.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>High-level resistance to traditional antibiotics, penicillin (25% to 100%) and tetracycline (10% to 100%) and the previously recommended ciprofloxacin (38% to 100%) was observed in all the countries. Overall, &gt;90% of less susceptible and resistant isolates to penicillin and ciprofloxacin were identified from 15 laboratories. Decreased susceptibility to ceftriaxone and cefpodoxime was reported by nine and eight centres, respectively. Resistance to spectinomycin (0.6% to 10.5%) and azithromycin (&lt;5%) was reported only by three centres. The increasing trends of resistance towards penicillin, tetracycline and ciprofloxacin were demonstrated in Bhutan, India, Sri Lanka and Thailand, and no large intercountry variations were evident. Insignificant trends in decreased susceptibility towards ceftriaxone were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Expansion of the WHO GASP facilitated enhanced AMR surveillance to meet the ongoing challenges of control of gonococcal AMR. The results highlight that the emergence of decreased susceptibility to ceftriaxone and resistance to spectinomycin and azithromycin will unavoidably lead to loss of therapeutic options, and a search for new effective agents needs to be initiated to respond to the emergence of resistant isolates.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2012-050904","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T14:33:46Z","timestamp":1384526026000},"page":"iv28-iv35","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Monitoring antimicrobial resistance in<i>Neisseria gonorrhoeae<\/i>in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis"],"prefix":"10.1136","volume":"89","author":[{"given":"Manju","family":"Bala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kakran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Members of the WHO GASP SEAR Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"2024051410033972000_89.Suppl_4.iv28.1","unstructured":"World Health Organization. Global surveillance network for gonococcal antimicrobial susceptibility. Geneva: World Health Organization, 1990, WHO\/VDT\/90-452."},{"key":"2024051410033972000_89.Suppl_4.iv28.2","doi-asserted-by":"publisher","DOI":"10.1177\/095646240001100209"},{"key":"2024051410033972000_89.Suppl_4.iv28.3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007435-200306000-00010","article-title":"Alarming increase in ciprofloxacin and penicillin resistant Neisseria gonorrhoeae isolates in New Delhi, India","volume":"30","author":"Bala","year":"2003","journal-title":"Sex Transm Dis"},{"key":"2024051410033972000_89.Suppl_4.iv28.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000154490.40381.15"},{"key":"2024051410033972000_89.Suppl_4.iv28.5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm238"},{"key":"2024051410033972000_89.Suppl_4.iv28.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000179906.57604.e3"},{"key":"2024051410033972000_89.Suppl_4.iv28.7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3329\/jhpn.v28i5.6152","article-title":"Monitoring antimicrobial susceptibility of Neisseria gonorrhoeae isolated from Bangladesh during 1997\u20132006: emergence and pattern of drug-resistant isolates","volume":"28","author":"Ahmed","year":"2010","journal-title":"J Health Population Nutrition"},{"key":"2024051410033972000_89.Suppl_4.iv28.8","first-page":"63","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in South-East Asia","volume":"15","author":"Bala","year":"2011","journal-title":"WHO South-East Asia Regional Health Forum"},{"key":"2024051410033972000_89.Suppl_4.iv28.9","first-page":"1","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007\u20132008","volume":"34","author":"WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes","year":"2010","journal-title":"Commun Dis Intell"},{"key":"2024051410033972000_89.Suppl_4.iv28.10","first-page":"1","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2009","volume":"35","author":"WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes","year":"2011","journal-title":"Commun Dis Intell"},{"key":"2024051410033972000_89.Suppl_4.iv28.11","first-page":"95","article-title":"Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2010","volume":"36","author":"WHO Western Pacific and South East Asian Gonococcal Antimicrobial Surveillance Programmes","year":"2012","journal-title":"Commun Dis Intell"},{"key":"2024051410033972000_89.Suppl_4.iv28.12","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050674"},{"key":"2024051410033972000_89.Suppl_4.iv28.13","unstructured":"World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: Department of Reproductive Health and Research WHO, 2012:P1\u201336. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501 (accessed 24 Mar 2013)."},{"key":"2024051410033972000_89.Suppl_4.iv28.14","unstructured":"Laboratory diagnosis of gonorrhoea. WHO regional publication, South East Asia series no 33. Geneva: World Health Organisation, 1999. http:\/\/w3.whosea.org\/book33 (accessed 24 Mar 2013)."},{"key":"2024051410033972000_89.Suppl_4.iv28.15","unstructured":"Tapsall JW. Antimicrobial testing and applications in the pathogenic Neisseria . In: Merlino J , ed Antimicrobial susceptibility testing: methods and practices with an Australian perspective. Sydney: Australian Society for Microbiology, 2004:P175\u201388."},{"key":"2024051410033972000_89.Suppl_4.iv28.16","unstructured":"Bell SM Pham JN Fisher GT . Antibiotic susceptibility testing by the CDS method. A manual for medical and veterinary laboratories. Fifth edition. 2009;P42\u201358. http:\/\/web.med.unsw.edu.au\/cdstest (accessed 24 Mar 2013)."},{"key":"2024051410033972000_89.Suppl_4.iv28.17","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Seventeenth Informational Supplement. CLSI document M100-S17 . Wayne, USA: Clinical and Laboratory Standards Institute, 2007."},{"key":"2024051410033972000_89.Suppl_4.iv28.18","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"key":"2024051410033972000_89.Suppl_4.iv28.19","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268809990148"},{"key":"2024051410033972000_89.Suppl_4.iv28.20","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182631c9f"},{"key":"2024051410033972000_89.Suppl_4.iv28.21","doi-asserted-by":"crossref","unstructured":"Kubanova A Frigo N Kubanov A . The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)\u2014national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008. Euro Surveill 2010;15:pii=19533. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19533 (accessed 28 Mar 2013).","DOI":"10.2807\/ese.15.14.19533-en"},{"key":"2024051410033972000_89.Suppl_4.iv28.22","doi-asserted-by":"crossref","unstructured":"Cole MJ Unemo M Hoffmann S . The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill 2011;16:pii:19995.","DOI":"10.2807\/ese.16.42.19995-en"},{"key":"2024051410033972000_89.Suppl_4.iv28.23","first-page":"215","article-title":"Antimicrobial-resistant gonorrhoea in Africa: An important public health threat in need of a regional gonococcal antimicrobial surveillance programme","volume":"26","author":"Lewis","year":"2011","journal-title":"South Afr J Epidemiol Infect"},{"key":"2024051410033972000_89.Suppl_4.iv28.24","unstructured":"Health Protection Agency. GRASP 2011 Report: the Gonococcal Resistance to Antimicrobials Surveillance Programme. Health Protection Agency Report, 2012."},{"key":"2024051410033972000_89.Suppl_4.iv28.25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"2024051410033972000_89.Suppl_4.iv28.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"2024051410033972000_89.Suppl_4.iv28.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks162"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2012-050904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:04:22Z","timestamp":1715706262000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2012-050904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":27,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2012-050904"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2012-050904","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}